Microbix Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Microbix's estimated annual revenue is currently $17.8M per year.(i)
  • Microbix's estimated revenue per employee is $155,000

Employee Data

  • Microbix has 115 Employees.(i)
  • Microbix grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.6M29N/AN/AN/A
Add Company

Microbix Biosystems Inc. develops biological products and technologies. The Company was founded as a producer of Infectious Disease Antigens, primarily for the diagnostics market. The Company invests in the virology business to build capacity and develop new products to address emerging market opportunities, while enhancing manufacturing and laboratory capabilities and technologies. Building on expertise in virology and protein biochemistry, the Company developed a pipeline of selected biological technologies: \r\n\r\nVIRUSMAX Influenza Virus Yield Enhancement Technology\r\nLumiSort™ Gender Selection Technology \r\nKinlytic® (Urokinase) Thrombolytic Drug

keywords:N/A

N/A

Total Funding

115

Number of Employees

$17.8M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Microbix's People

NameTitleEmail/Phone
1
Scientist, Research and DevelopmentReveal Email/Phone
2
Director Research and DevelopmentReveal Email/Phone
3
VP, Scientific AffairsReveal Email/Phone
4
Director, QCReveal Email/Phone
5
Quality Assurance SpecialistReveal Email/Phone
6
Director ManufacturingReveal Email/Phone
7
CFOReveal Email/Phone
8
Chief Operating OfficerReveal Email/Phone
9
Quality Control Laboratory Technician IReveal Email/Phone
10
Senior Summer StudentReveal Email/Phone

Microbix News

2022-04-17 - Microbix Presenting Respiratory Virus Controls Data at Two ...

MISSISSAUGA, Ontario, April 19, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences...

2022-04-17 - Microbix Biosystems Presenting Respiratory Virus Controls Data at Two Events

Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably viral...

2022-03-30 - Microbix Invests to Further Scale Its Business

MISSISSAUGA, Ontario, March 29, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.7M11511%N/A
#2
$49M115-10%N/A
#3
$17.9M11622%N/A
#4
$17.4M11717%N/A
#5
$31.2M1178%N/A